<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is the sixth leading cause of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related mortality worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>Previously, <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> was mainly squamous cell, presenting late with <z:hpo ids='HP_0002015'>dysphagia</z:hpo> and <z:hpo ids='HP_0001824'>weight loss</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>AIMS: To examine the distribution of <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> histopathology at a large, urban hospital; to determine the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> stage and symptoms at presentation; and to evaluate the impact of endoscopic surveillance in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: From 1999 to 2004, <z:hpo ids='HP_0000001'>all</z:hpo> patients diagnosed with <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> were evaluated retrospectively for demographics and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> stage at presentation using endoscopic ultrasonography and computerized tomography </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: A total of 131 patients were included </plain></SENT>
<SENT sid="5" pm="."><plain>81% of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> were <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>; most localized to the distal oesophagus (97%) </plain></SENT>
<SENT sid="6" pm="."><plain>Patients presented with <z:hpo ids='HP_0002015'>dysphagia</z:hpo> (56%), pain (30%) and/or <z:hpo ids='HP_0001824'>weight loss</z:hpo> (16%) </plain></SENT>
<SENT sid="7" pm="."><plain>Irrespective of histology, locally advanced lesions accounted for most cases </plain></SENT>
<SENT sid="8" pm="."><plain>Thirteen patients had lesions detected in Barrett's surveillance; these were early or intermediate stage in nine patients, but late stage in four patients </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: <z:mp ids='MP_0009308'>Adenocarcinoma</z:mp> has become the dominant histologic subtype, comprising 81% of proven <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Despite a change in histopathology, most <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> are diagnosed at an advanced stage, presenting with <z:hpo ids='HP_0002015'>dysphagia</z:hpo>, pain and/or <z:hpo ids='HP_0001824'>weight loss</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Endoscopic surveillance of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> allows earlier diagnosis of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in most, but not <z:hpo ids='HP_0000001'>all</z:hpo>, patients </plain></SENT>
</text></document>